A. Herrán

发表

The early phases of anxiety disorders: from prevention to treatment.

J. Vázquez-Barquero, J. Vázquez-Bourgon, A. Herrán, 2013, Modern trends in pharmacopsychiatry.

Neuroleptic malignant syndrome in AIDS 781 Table Summary of case histories of AIDS patients with NMS

J. Riancho, A. Herrán, Jose L Hemaindez, 2003 .

Neuroleptic malignant syndrome in the acquired immunodeficiency syndrome.

J. Riancho, A. Herrán, J. L. Hernández, 1997, Postgraduate medical journal.

Recognition and treatment of mental disorders in primary health care.

J. Vázquez-Barquero, A. Herrán, 1999, Annals of Saudi medicine.

Diagnostic Accuracy in the First 5 min of a Psychiatric Interview. Impact of the information given by patients.

J. Vázquez-Barquero, A. De Santiago, A. Herrán, 2001, Psychotherapy and psychosomatics.

Diagnostic Accuracy in the First 5 minof a Psychiatric Interview

J. Vázquez-Barquero, A. De Santiago, A. Herrán, 2001, Psychotherapy and Psychosomatics.

Quality of life in early phases of panic disorder: predictive factors.

J. Ayuso-Mateos, J. Vázquez-Barquero, M. Carrera, 2006, Journal of affective disorders.

Tardive dyskinesia associated with olanzapine.

J. Vázquez-Barquero, A. Herrán, 1999, Annals of internal medicine.

Effects of long-term treatment with antipsychotics on serum leptin levels

J. Vázquez-Barquero, J. Amado, M. García-Unzueta, 2001, British Journal of Psychiatry.

Folate levels in psychiatric outpatients

J. Vázquez-Barquero, J. Amado, M. García-Unzueta, 1999, Psychiatry and clinical neurosciences.

[Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): initial phase of development and pilot study. Cantabria disability work group].

J. Vázquez-Barquero, T. B. Ustün, S. Herrera Castanedo, 2000, Actas espanolas de psiquiatria.

The acute phase response in panic disorder.

J. Vázquez-Barquero, M. García-Unzueta, A. Herrán, 2005, The international journal of neuropsychopharmacology.

Increased Bone Remodeling in First-Episode Major Depressive Disorder

J. Vázquez-Barquero, J. González‐Macías, J. Amado, 2000, Psychosomatic medicine.

Cantabria First-Episode Schizophrenia Study: three-year follow-up

G. Dunn, J. Vázquez-Barquero, A. Herrán, 1999, British Journal of Psychiatry.

Alterations of liver function test in patients treated with antipsychotics

J. Vázquez-Barquero, J. Amado, M. García-Unzueta, 2003, Journal of clinical laboratory analysis.

Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics

J. Vázquez-Barquero, J. Amado, M. García-Unzueta, 2000, Psychiatry Research.

Quality of life in patients with schizophrenia in five European countries: the EPSILON study

M. Ruggeri, J. Vázquez-Barquero, A. Schene, 2002, Acta psychiatrica Scandinavica.

[Referral of patients with mental disorders from primary care to mental health units].

J. Vázquez-Barquero, A. Herrán, J. Díez‐Manrique, 2000, Actas espanolas de psiquiatria.

Gender differences in living with schizophrenia. A cross-sectional European multi-site study

A. Schene, M. Tansella, G. Thornicroft, 2002, Schizophrenia Research.

Determinants of smoking behaviour in outpatients with schizophrenia

J. Vázquez-Barquero, A. Herrán, A. D. Santiago, 2000, Schizophrenia Research.

Analysis of positive and negative symptoms in schizophrenia. A study from a population of long‐term outpatients

J. Vázquez-Barquero, A. Herrán, L. Palacios-Araus, 1995, Acta psychiatrica Scandinavica.

Neuropletic malignant syndrome and olanzapine.

J. Vázquez-Barquero, F. Díez-Manrique, A. Herrán, 2000, Journal of clinical psychopharmacology.

Provision of services for people with schizophrenia in five European regions

S. Hülsmann, J. Vázquez-Barquero, A. Schene, 2002, Social Psychiatry and Psychiatric Epidemiology.

Manifesto for a European Anxiety Disorders Research Network

J. Vázquez-Barquero, A. Metspalu, N. Fineberg, 2010, European Neuropsychopharmacology.

Mental health in primary care

G. Dunn, J. Vázquez-Barquero, C. Iglesias, 1997, British Journal of Psychiatry.

Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study.

M. Ruggeri, J. Vázquez-Barquero, A. Schene, 2005, Comprehensive psychiatry.

Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short‐term outcome

J. Vázquez-Barquero, M. Carrera, A. Herrán, 2006, Acta psychiatrica Scandinavica.

Can personality traits help us explain disability in chronic schizophrenia?

J. Vázquez-Barquero, A. Herrán, M. J. Cuesta, 2006, Psychiatry and clinical neurosciences.

Treating alcohol dependence. Chlormethiazole is widely used in Europe.

J. Vázquez-Barquero, A. Herrán, 1997, British medical journal.

Treatment of Diogenes Syndrome with Risperidone

J. Vázquez-Barquero, A. Herrán, 1999 .

Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.

J. Vázquez-Barquero, M. Carrera, M. García-Unzueta, 2006, Journal of clinical psychopharmacology.

Relationship between personality traits and panic disorder.

A. Herrán, D. Sierra-Biddle, Bárbara Navarro, 2013, Actas espanolas de psiquiatria.

Recognition of depression and anxiety in primary care

G. Dunn, J. Vázquez-Barquero, A. Herrán, 1999, BMJ.

Mental health in primary care

G. Dunn, J. Vázquez-Barquero, C. Iglesias, 1997, British Journal of Psychiatry.

Treating alcohol dependence. Chlormethiazole is widely used in Europe.

J. Vázquez-Barquero, A. Herrán, 1997, BMJ.

Mental Health in Primary Care

J. Vázquez-Barquero, J. Bleidorn, A. Herrán, 1997, British Journal of Psychiatry.